Search - tctmd.com

Displaying 861 - 880 of 1172

Sort: Relevancy | Date

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

Presenter: Daniel S. Berman, Pamela S. Douglas, Jelmer Westra

October 31, 2016

Presentation TCT 2016

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Presenter: Lutz Buellesfeld, Raj Makkar, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

TCT 628: Very Long-Term (Up To 23 Years) Follow-Up After Successful Mitral Balloon Valvuloplasty In A Large Series Of Patients With Rheumatic Mitral Stenosis

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Presenter: Michael J. Lim, Payam Dehghani

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR

Presenter: Dmitriy N. Feldman, Rahul Sakhuja

October 31, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

Canada Presents: Role of IVUS, OCT and FFR in the Assessment of LM Stenosis, and PCI Guidance

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Jean-Michel Paradis

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr.

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti

October 30, 2016

Presentation TCT 2016

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat?

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison

October 30, 2016

Presentation TCT 2016

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison

October 30, 2016

Presentation TCT 2016

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Presenter: A. Pieter Kappetein, Allan Schwartz, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Antonio Enrique Dager

October 30, 2016

Presentation TCT 2016

Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR

Presenter: A. Pieter Kappetein, Allan Schwartz, Howard C. Herrmann

October 30, 2016

Presentation TCT 2016

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Chris Meduri

October 30, 2016

Presentation TCT 2016

Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis

Presenter: A. Pieter Kappetein, Allan Schwartz, Philippe Pibarot

October 30, 2016

Presentation TCT 2016

Treatment of Bifurcation Stenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Presenter: A. Pieter Kappetein, Allan Schwartz, Mathew Williams

October 30, 2016

Presentation TCT 2016

TCT 513: Discordance In Stenosis Classification by Pressure-Only Indices of Stenosis Severity is Related to Differences in Coronary Flow Reserve the RESOLVING DISCORD Study

Presenter: Michalis Hamilos, Pim A.L. Tonino

October 30, 2016

Advertisement

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

TCT 628: Very Long-Term (Up To 23 Years) Follow-Up After Successful Mitral Balloon Valvuloplasty In A Large Series Of Patients With Rheumatic Mitral Stenosis

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Canada Presents: Role of IVUS, OCT and FFR in the Assessment of LM Stenosis, and PCI Guidance

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat?

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis

Treatment of Bifurcation Stenosis

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

TCT 513: Discordance In Stenosis Classification by Pressure-Only Indices of Stenosis Severity is Related to Differences in Coronary Flow Reserve the RESOLVING DISCORD Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content